DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key acute heart failure patient populations covering 171 countries and more…
DRG Epidemiology’s coverage of scleroderma (systemic sclerosis) (SSc) comprises epidemiological estimates of key patient populations in14 mature and emerging pharmaceutical markets worldwide. We…
The biosimilar/noninnovator sector of the endocrinology market is evolving. Eli Lilly/Boehringer Ingelheim’s Abasaglar/Basaglar was the first biosimilar/noninnovator insulin glargine to launch in…
DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of gastric cancer for each…
DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of gastric cancer for each…
DRG Epidemiology's coverage of esophageal cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology's coverage of esophageal cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of gastric cancer for each…
DRG Epidemiology's coverage of esophageal cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology's coverage of esophageal cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of gastric cancer for each…
DRG Epidemiology's coverage of esophageal cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
The treatment of renal cell carcinoma has long been dominated by targeted treatments, including mTOR and angiogenesis inhibitors. However, the introduction of immune checkpoint inhibitors has…
Alopecia areata (AA) is an inflammatory autoimmune skin disease characterized by varying degrees of hair loss. The host immune system targets anagen hair follicles. The primary treatment goal is to…
DRG Epidemiology’s coverage of gastroesophageal reflux disease (GERD) comprises epidemiological estimates of key patient populations in mature markets. We report the total prevalence of GERD for…